Comparative mortality and neurological outcomes in term newborns with severe perinatal asphyxia treated with combined magnesium sulphate and erythropoietin or magnesium sulfate alone
Journal of African Neonatology · 22.04.2026 · 3 (4) · 164-170
DOI: 10.4314/jan.v3i4.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of African Neonatology, online erschienen am 22.04.2026. Verfasst von Joseph N. Ajanwenyi und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Severeperinatal asphyxia (PA) remains aleading cause of neonatal mortality and long-term neurologicaldisability in low- and middleincome countries (LMICs) wheretherapeutic hypothermia is largelyunavailable. Pharmacological neuroprotective agents may offer coste f f e c t i v e a l t e r n a t i v e s .
Methods
The institutional EthicsCommittee approved the protocol.We conducted a prospective, randomized, controlled trial oferythropoietin and magnesiumsulfate on term neonates with severe PA (hypoxic-ischemic encephalopathy [HIE] stages II–III)at the Federal Medical Centre,Asaba, Nigeria, in 2024. Theywere randomized to either MgSO₄plus EPO (Group I, n = 50) orMgSO₄ alone (Group II, n = 50).Group II. The primary outcomewas in-hospital 28-day mortality.Secondary outcomes includedtime to resolution of neurologicsymptoms and neurological statusa t 2 8 d a y s .
Results
130/ 1370 (9.4%) inhospital deliveries had PA; 598 ofthese were admitted. 205/ 803(25.53%) total admissions to theNeonatal unit were outborn; 88had PA. Mortality was significantly lower in group I (4%; 2/50)compared with group II (18%;9/50, p = 0.025). Combinationtherapy resulted in faster seizurecontrol (1.34 ± 1.61 vs 2.71 ± 2.23days, p = 0.002), earlier recoveryof: suck (4.7 vs 7.9 days, p =0.014), grasp reflex (5.3 vs 8.5days, p = 0.028), and tone normalization (16.1 vs 21.3 days, p =0.037). Logistic regression identified low birth weight, low APGAR score, and out-of-hospitaldelivery as significant predictorso f m o r t a l i t y .
Conclusion
Combination therapywith Erythropoietin significantlyreduced mortality and improvedneurological recovery in term neonates with severe PA. This combination could representa feasible,cost-effective alternative forLMICs
Zitieren
APA
Ajanwenyi, J. N., Okolo, A. A., Okike, C. O., & Chukwumah, O. U. (2026). Comparative mortality and neurological outcomes in term newborns with severe perinatal asphyxia treated with combined magnesium sulphate and erythropoietin or magnesium sulfate alone. Journal of African Neonatology, 3(4), 164-170. https://doi.org/10.4314/jan.v3i4.5
Vancouver
Ajanwenyi JN, Okolo AA, Okike CO, Chukwumah OU. Comparative mortality and neurological outcomes in term newborns with severe perinatal asphyxia treated with combined magnesium sulphate and erythropoietin or magnesium sulfate alone. Journal of African Neonatology. 2026;3(4):164-170. doi:10.4314/jan.v3i4.5
BibTeX
@article{Ajanwenyi2026,
author = {Ajanwenyi, Joseph N. and Okolo, Angela A. and Okike, Clifford O. and Chukwumah, Osaretin U.},
title = {Comparative mortality and neurological outcomes in term newborns with severe perinatal asphyxia treated with combined magnesium sulphate and erythropoietin or magnesium sulfate alone},
journal = {Journal of African Neonatology},
year = {2026},
volume = {3},
number = {4},
pages = {164--170},
doi = {10.4314/jan.v3i4.5}
}
EUVIMED